Low-dose oral misoprostol for induction of labor: A systematic review

Obstetrics and Gynecology

Volumn 113, Issue 2 PART 1, 2009, Pages 374-383

  Kundodyiwa, Timothy W ^b   Alfirevic, Zarko ^b   Weeks, Andrew D ^a,b  

^a LIVERPOOL WOMEN'S NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN E2; OXYTOCIC AGENT;

ARTICLE; CESAREAN SECTION; DATA BASE; FETUS HEART RATE; GESTATIONAL AGE; HUMAN; LABOR INDUCTION; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; DOSE RESPONSE; FEMALE; INTRAVAGINAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RISK; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; CESAREAN SECTION; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LABOR, INDUCED; MISOPROSTOL; OXYTOCICS; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; TREATMENT OUTCOME;

EID: 60549107918     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181945859     Document Type: Article

References (36)

1. Macfarlane A, Mugford M. Care of mothers and babies. In: Birth counts: statistics of pregnancy and childbirth. London (UK): The Stationery Office; 2000. p. 191-242.
2. Rayburn WF, Zhang J. Rising rates of labor induction: present concerns and future strategies. Obstet Gynecol 2002;100: 164-7.
3. Zhang J, Yancey MK, Henderson CE. U.S. national trends in labor induction, 1989-1998. J Reprod Med 2002;47:120-4.
4. Royal College of Obstetricians and Gynaecologists. Induction of labour. Evidence-based Clinical Guideline Number 9. London (UK): RCOG Press; 2001.
5. Justus Hofmeyr G. Induction of labor with an unfavorable cervix. Best Pract Res Clin Obstet Gynaecol 2003;17:777-94.
6. American College of Obstetricians and Gynecologists. Induction of Labor. ACOG Practice Bulletin 10. Washington (DC): ACOG; 1999.
7. Watkinson G, Hopkins A, Akbar FA. The therapeutic efficacy of misoprostol in peptic ulcer disease. Postgrad Med J. 1988;64 suppl:60-77.
8. Alfirevic Z, Weeks A. Oral misoprostol for induction of labor. The Cochane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD001338. DOI: 10.1002/14651858.CD001388.
9. Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and labour induction in late pregnancy. The Cochane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD000941. DOI: 10.1002/14651858.CD000941.
10. Goldberg AB, Wing DA. Induction of labor: the misoprostol controversy. J Midwifery Womens Health 2003;48:244-8.
11. Wing DA, Paul RH. A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction [published erratum appears in Am J Obstet Gynecol 1997;176:1423]. Am J Obstet Gynecol 1996;175:158-64.
12. Wing DA. A benefit-risk assessment of misoprostol for cervical ripening and labour induction. Drug Saf 2002;25:665-76.
13. WHO Expert Committee. The selection and use of essential medicines. World Health Organ Tech Rep Ser 2007;1-162, back cover.
14. Weeks A, Alfirevic Z, Faundes A, Hofmeyr GJ, Safar P, Wing D. Misoprostol for induction of labor with a live fetus. Int J Gynaecol Obstet 2007;99 suppl:S194-7.
15. Weeks AD, Fiala C, Safar P. Misoprostol and the debate over off-label drug use. BJOG 2005;112:269-72.
16. Williams MC, Tsibris JC, Davis G, Baiano J, O'brien WF. Dose variation that is associated with approximated onequarter tablet doses of misoprostol. Am J Obstet Gynecol 2002;187:615-9.
17. Hofmeyr GJ, Alfirevic Z, Matonhodze B, Brocklehurst P, Campbell E, Nikodem VC. Titrated oral misoprostol solution for induction of labour: a multi-centre, randomised trial. BJOG 2001;108:952-9.
18. Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 2007;99 suppl:S160-7.
19. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12.
20. De A, Bagga R, Gopalan S. The routine use of oxytocin after oral misoprostol for labour induction in women with an unfavorable cervix is not of benefit. Aust N Z J Obstet Gynaecol 2006;46:323-9.
21. How HY, Leaseburge L, Khoury JC, Siddiqi TA, Spinnato JA, Sibai BM. A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. Am J Obstet Gynecol 2001;185:911-5.
22. Moodley J, Venkatachalam S, Songca P. Misoprostol for cervical ripening at and near term-a comparative study. S Afr Med J 2003;93:371-4.
23. Dallenbach P, Boulvain M, Viardot C, Irion O. Oral misoprostol or vaginal dinoprostone for labor induction: a randomized controlled trial. Am J Obstet Gynecol 2003;188:162-7.
24. Dodd JM, Crowther CA, Robinson JS. Oral misoprostol for induction of labour at term: randomised controlled trial. BMJ 2006;332:509-13.
25. Dodd JM, Crowther CA, Robinson JS. Oral misoprostol versus intravenous oxytocin for induction of labor following artificial or spontaneous rupture of membranes: a randomized controlled trial. In: Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3-6; Perth (Australia): Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006. p. 258.
26. Matonhodze BB, Hofmeyr GJ, Levin J. Labour induction at term-a randomised trial comparing Foley catheter plus titrated oral misoprostol solution, titrated oral misoprostol solution alone, and dinoprostone. S Afr Med J 2003;93:375-9.
27. Cheng SY, Ming H, Lee JC. Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial. Obstet Gynecol 2008;111:119-25.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
29. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
30. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354:1896-900.
31. Higgins JPT, Green S, editors. Cochane handbook for systematic reviews of interventions version 5.0.0 [Updated September 2008]. Available at: www.cochane-handbook.org Retrieved July 1, 2008.
32. Sanchez-Ramos L, Kaunitz AM. Misoprostol for cervical ripening and labor induction: a systematic review of the literature. Clin Obstet Gynecol 2000;43:475-88.
33. Crane JM, Butler B, Young DC, Hannah ME. Misoprostol compared with prostaglandin E2 for labour induction in women at term with intact membranes and unfavourable cervix: a systematic review. BJOG 2006;113:1366-76.
34. Quenby S, Pierce SJ, Brigham S, Wray S. Dysfunctional labor and myometrial lactic acidosis [published erratum appears in Obstet Gynecol 2004;103:1344]. Obstet Gynecol 2004;103:718-23.
35. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-92.
36. Arvidsson C, Hellborg M, Gemzell-Danielsson K. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone. Eur J Obstet Gynecol Reprod Biol 2005;123:87-91.